The heme oxygenase inducer hemin protects against cardiac dysfunction and ventricular fibrillation in ischaemic/reperfused rat hearts: role of connexin 43

References

• Söti C., Nagy E., Giricz Z., Vígh L., Csermely P., Ferdinandy P. Heat shock proteins as emerging therapeutic targets. Br J Pharmacol 2005; 146: 769–80
   PubMed Web of Science ®Google Scholar
• Otterbein L. E., Soares M. P., Yamashita K., Bach F. H. Heme oxygenase‐1: unleashing the protective properties of heme. Trends Immunol 2003; 24: 449–55
   PubMed Web of Science ®Google Scholar
• Morse D., Choi A. M. K. Heme oxygenase‐1: the “emerging molecule” has arrived. Am J Respir Cell Mol Biol 2002; 27: 8–16
   PubMed Web of Science ®Google Scholar
• Morita T., Perrella M. A., Lee M‐E., Kourembanas S. Smooth muscle cell‐derived carbon monoxide is a regulator of vascular cGMP. Proc Natl Acad Sci USA 1995; 92: 1475–9
   PubMed Web of Science ®Google Scholar
• Wang R., Wu L., Wang Z. The direct effect of carbon monoxide on KCa channels in vascular smooth muscle cells. Pflügers Arch Eur J Physiol 1997; 434: 285–91
   PubMed Web of Science ®Google Scholar
• Brune B., Ullrich V. Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase. Mol Pharmacol 1987; 32: 497–504
   PubMed Web of Science ®Google Scholar
• Duckers H. J., Boehm M., True A. L., Yet S‐F., San H., Park J. L., et al. Heme oxygenase‐1 protects against vascular constriction and proliferation. Nat Med 2001; 7: 693–8
   PubMed Web of Science ®Google Scholar
• Brouard S., Otterbein L. E., Anrather J., Tobiasch E., Bach F. H., Choi A. M. K., et al. Carbon monoxide generated by heme oxygenase‐1 suppresses endothelial cell apoptosis. J Exp Med 2000; 192: 1015–25
   PubMed Web of Science ®Google Scholar
• Otterbein L. E., Bach F. H., Alam J., Soares M., Tao Lu H., Wysk M., et al. Carbon monoxide has anti‐inflammatory effects involving the mitogen‐activated protein kinase pathway. Nat Med 2000; 6: 422–8
   PubMed Web of Science ®Google Scholar
• Csonka C., Varga E., Kovacs P., Ferdinandy P., Blasig I. E., Szilvassy Z., et al. Heme oxygenase and cardiac function in ischemic/reperfused rat hearts. Free Radic Biol Med 1999; 27: 119–26
   PubMed Web of Science ®Google Scholar
• Lakkisto P., Palojoki E., Bäcklund T., Saraste A., Tikkanen I., Voipio‐Pulkki L‐M., et al. Expression of heme oxygenase‐1 in response to myocardial infarction in rats. J Mol Cell Cardiol 2002; 34: 1357–65
   PubMed Web of Science ®Google Scholar
• Bak I., Papp G., Turoczi T., Varga E., Szendrei L., Vecsernyes M., et al. The role of heme oxygenase‐related carbon monoxide and ventricular fibrillation in ischemic/reperfused hearts. Free Radic Biol Med 2002; 33: 639–48
   PubMed Web of Science ®Google Scholar
• Bak I., Varadi J., Nagy N., Vecsernyes M., Tosaki A. The role of exogenous carbon monoxide in the recovery of post‐ischemic cardiac function in buffer perfused isolated rat hearts. Cell Mol Biol (Noisy‐le‐grand) 2005; 51: 453–9
   PubMed Web of Science ®Google Scholar
• Clark J. E., Foresti R., Sarathchndra P., Kaur H., Green C. J., Motterlini R. Heme oxygenase‐1 derived bilirubin ameliorates postischemic dysfunction. Am J Physiol Heart Circ Physiol 2000; 278: H643–51
   PubMed Web of Science ®Google Scholar
• Csonka C., Szilvássy Z., Fülöp F., Páli T., Blasig I. E., Tosaki A., et al. Classic preconditioning decreases the harmful accumulation of nitric oxide during ischemia and reperfusion in rat hearts. Circulation 1999; 100: 2260–6
   PubMed Web of Science ®Google Scholar
• Ferdinandy P., Das D. K., Tosaki A. Pacing‐induced ventricular fibrillation leading to oxygen free radical production in aerobically perfused rat hearts. J Mol Cell Cardiol 1993; 25: 683–92
   PubMed Web of Science ®Google Scholar
• Motterlini R., Gonzales A., Foresti R., Clark J. E., Green C. J., Winslow R. M. Heme oxygenase‐1‐derived carbon monoxide contributes to the suppression of acute hypertensive responses in vivo. Circ Res 1998; 83: 568–77
   PubMed Web of Science ®Google Scholar
• Tsuchihashi S., Zhai Y., Bo Q., Busuttil R. W., Kupiec‐Weglinski J. W. Heme oxygenase‐1 mediated cytoprotection against liver ischemia and reperfusion injury: inhibition of type‐1 interferon signalling. Transplantation 2007; 83: 1628–34
   PubMed Web of Science ®Google Scholar
• Szabo M. E., Gallyas E., Bak I., Rakotovao A., Boucher F., de Leiris J., et al. Heme oxygenase‐1‐related carbon monoxide and flavonoids in ischemic/reperfused rat retina. Invest Ophthalmol Vis Sci 2004; 45: 3727–32
   PubMed Web of Science ®Google Scholar
• Balogun E., Foresti R., Green C. J., Motterlini R. Changes in temperature modulate heme oxygenase‐1 induction by curcumin in renal epithelial cells. Biochem Biophys Res Commun 2003; 308: 950–5
   PubMed Web of Science ®Google Scholar
• Guo Y., Stein A. B., Wu W‐J., Tan W., Zhu X., Li Q‐H., et al. Administration of a CO‐releasing molecule at the time of reperfusion reduces infarct size in vivo. Am J Physiol Heart Circ Physiol 2004; 286: H1649–53
   PubMed Web of Science ®Google Scholar
• Hangaishi M., Ishizaka N., Aizawa T., Kurihara Y., Taguchi J., Nagai R., et al. Induction of heme oxygenase‐1 can act protectively against cardiac ischemia/reperfusion in vivo. Biochem Biophys Res Commun 2000; 279: 582–8
   PubMed Web of Science ®Google Scholar
• Yang G., Nguyen X., Ou J., Rekulapelli P., Stevenson D. K., Dennery P. A. Unique effects of zinc protoporphyrin on HO‐1 induction and apoptosis. Blood 2001; 97: 1306–13
   PubMed Web of Science ®Google Scholar
• Lu R., Peng J., Xiao L., Deng H‐W., Li Y‐J. Heme oxygenase‐1 pathway is involved in delayed protection induced by heat stress against ischemia‐reperfusion injury. Int J Cardiol 2002; 82: 133–40
   PubMed Web of Science ®Google Scholar
• Yet S‐F., Tian R., Layne M. D., Wang Z. Y., Maemura K., Solovyeva M., et al. Cardiac‐specific expression of heme oxygenase‐1 protects against ischemia and reperfusion injury in transgenic mice. Circ Res 2001; 89: 168–73
   PubMed Web of Science ®Google Scholar
• Bazzani C., Guarini S., Botticelli A. R., Zaffe D., Tomasi A., Bini A., et al. Protective effect of melanocortin peptides in rat myocardial ischemia. J Pharmacol Exp Ther 2001; 297: 1082–7
   PubMed Web of Science ®Google Scholar
• Vecsernyes M., Juhasz B., Der P., Kocsan R., Feher P., Bacskay I., et al. The administration of α‐melanocyte‐stimulating hormone protects the ischemic/reperfused myocardium. Eur J Pharmacol 2003; 470: 177–83
   PubMed Web of Science ®Google Scholar
• Mioni C., Giuliani D., Cainazzo M. M., Leone S., Iannone C., Bazzani C., et al. Further evidence that melanocortins prevent myocardial reperfusion injury by activating melanocortin MC3 receptors. Eur J Pharmacol 2003; 477: 227–34
   PubMed Web of Science ®Google Scholar
• Juhasz B., Der P., Szodoray P., Gesztelyi R., Lekli I., Bak I., et al. Adrenocorticotrope hormone fragment (4–10) attenuates the ischemia/reperfusion‐induced cardiac injury in isolated rat hearts. Antioxid Redox Signal 2007; 9: 1851–61
   PubMed Web of Science ®Google Scholar
• Bak I., Szendrei L., Turoczi T., Papp G., Joo F., Das D. K., et al. Heme oxygenase‐1 related carbon monoxide production and ventricular fibrillation in isolated/reperfused mouse myocardium. FASEB J 2003; 17: 2133–5
   PubMed Web of Science ®Google Scholar
• Kharitonov V. G., Sharma V. S., Pilz R. B., Magde D., Koesling D. Basis of guanylate cyclase activation by carbon monoxide. Proc Natl Acad Sci USA 1995; 92: 2568–71
   PubMed Web of Science ®Google Scholar
• Pabla R., Bland‐Ward P., Moore P. K., Curtis M. J. An endogenous protectant effect of cardiac cyclic GMP against reperfusion‐induced ventricular fibrillation in the rat. Br J Pharmacol 1995; 116: 2923–30
   PubMed Web of Science ®Google Scholar
• Szilvassy Z., Ferdinandy P., Bor P., Jakab I., Lonovics J., Koltai M. Ventricular overdrive pacing‐induced anti‐ischemic effect: a conscious rabbit model of preconditioning. Am J Physiol 1994; 266: H2033–44
   PubMed Web of Science ®Google Scholar
• De Mello W. C. Atrial natriuretic factor reduces cell coupling in the failing heart, an effect mediated by cyclic GMP. J Cardiovasc Pharmacol 1998; 32: 75–9
   PubMed Web of Science ®Google Scholar
• Agullo L., Garcia‐Dorado D., Inserte J., Paniagua A., Pyrhönen P., Llevadot J., et al. L‐arginine limits myocardial cell death secondary to hypoxia‐reoxygenation by a cGMP‐dependent mechanism. Am J Physiol Heart Circ Physiol 1999; 276: H1574–80
   Web of Science ®Google Scholar
• Csont T., Páli T., Szilvássy Z., Ferdinandy P. Lack of correlation between myocardial nitric oxide and cyclic guanosine monophosphate content in both nitrate‐tolerant and nontolerant rats. Biochem Pharmacol 1998; 56: 1139–44
   PubMed Web of Science ®Google Scholar
• Severs N. J., Coppen S. R., Dupont E., Yeh H‐I., Ko Y‐S., Matsushita T. Gap junction alterations in human cardiac disease. Cardiovasc Res 2004; 62: 368–77
   PubMed Web of Science ®Google Scholar
• Schwanke U., Konietzka I., Duschin A., Li X., Schulz R., Heusch G. No ischemic preconditioning in heterozygous connexin43‐deficient mice. Am J Physiol Heart Circ Physiol 2002; 283: H1740–2
   PubMed Web of Science ®Google Scholar
• Schulz R., Gres P., Skyschally A., Duschin A., Belosjorow S., Konietzka I., et al. Ischemic preconditioning preserves connexin 43 phosphorylation during sustained ischemia in pig hearts in vivo. FASEB J 2003; 17: 1355–7
   PubMed Web of Science ®Google Scholar
• Vetterlein F., Mühlfeld C., Cetegen C., Volkmann R., Schrader C., Hellige G. Redistribution of connexin43 in regional acute ischemic myocardium: influence of ischemic preconditioning. Am J Physiol Heart Circ Physiol 2006; 291: H813–9
   PubMed Web of Science ®Google Scholar
• Boengler K., Schulz R., Heusch G. Connexin 43 signaling and cardioprotection. Heart 2006; 92: 1724–7
   PubMed Web of Science ®Google Scholar
• Crow D. S., Beyer E. C., Paul D. L., Kobe S. S., Lau A. F. Phosphorylation of connexin43 gap junction protein in uninfected and rous sarcoma virus‐transformed mammalian fibroblasts. Mol Cell Biol 1990; 10: 1754–63
   PubMed Web of Science ®Google Scholar
• Garcia‐Dorado D., Rodriguez‐Sinovas A., Ruiz‐Meana M. Gap junction‐mediated spread of cell injury and death during myocardial ischemia‐reperfusion. Cardiovasc Res 2004; 61: 386–401
   PubMed Web of Science ®Google Scholar
• Li X., Heinzel F. R., Boengler K., Schulz R., Heusch G. Role of connexin 43 in ischemic preconditioning does not involve intercellular communication through gap junctions. J Mol Cell Cardiol 2004; 36: 161–3
   PubMed Web of Science ®Google Scholar
• Chakder S., Rathi S., Ma X‐L., Rattan S. Heme oxygenase inhibitor zinc protoporphyrin IX causes an activation of nitric oxide synthase in the rabbit internal anal sphincter. Am Soc Pharmacol Exp Ther 1996; 277: 1376–82
   Web of Science ®Google Scholar
• Meffert M. K., Haley J. E., Schuman E. M., Schulman H., Madison D. V. Inhibition of hippocampal heme oxygenase, nitric oxide synthase, and long‐term potentiation by metalloporphyrins. Neuron 1994; 13: 1225–33
   PubMed Web of Science ®Google Scholar
• Serfass L., Burstyn J. N. Effect of heme oxygenase inhibitors on soluble guanylyl cyclase activity. Arch Biochem Biophys 1998; 359: 8–16
   PubMed Web of Science ®Google Scholar
• Kawahara K., Takase M., Yamauchi Y. Increased vulnerability to ischemia/reperfusion‐induced ventricular tachyarrhythmias by pre‐ischemic inhibition of nitric oxide synthase in isolated rat hearts. Cardiovasc Pathol 2003; 12: 49–56
   PubMed Web of Science ®Google Scholar
• Stein A. B., Tang X. L., Guo Y., Xuan Y. T., Dawn B., Bolli R. Delayed adaptation of the heart to stress: late preconditioning. Stroke 2004; 35: 2676–9
   PubMed Web of Science ®Google Scholar